Literature DB >> 18482948

Temporary external lumbar drainage for reducing elevated intracranial pressure in HIV-infected patients with cryptococcal meningitis.

Weerawat Manosuthi1, Somnuek Sungkanuparph, Suthat Chottanapund, Somsit Tansuphaswadikul, Sukanya Chimsuntorn, Putthiporn Limpanadusadee, Peter G Pappas.   

Abstract

The aim of this study was to investigate safety and impact of temporary external lumbar drainage for continuous release of cerebrospinal fluid among patients with HIV-associated cryptococcal meningitis and elevated intracranial pressure (ICP). We conducted a retrospective cohort study among patients with cryptococcal meningitis in whom temporary external lumbar drains were placed to reduce intractable elevated ICP between January 2002 and December 2005. Patients were followed for three months after the procedure. Among 601 HIV-infected patients with cryptococcal meningitis, 54 (8.9%) underwent lumbar drain placement. Of these patients, mean age was 33 years and 80% were males. The median duration of an indwelling lumbar drain was seven days. There were 61 placement procedures among 54 patients, totalling to 473 device-days of observation. Overall incidence of secondary bacterial infections was 6.3 per 1000 device-days, and three (4.9%) of 61 catheters became secondarily infected with nosocomially acquired bacteria. All three drains were removed and appropriate antibiotics were given. There was no difference in median duration of placement between infected and uninfected drains (six days vs. seven days, P=0.572). The overall mortality rate was 5.6% in this cohort of 54 patients. In conclusion, the incidence of nosocomial infection of external lumbar drains is low. In resource-limited settings, the use of temporary external lumbar drainage is a safe and effective management strategy for intractable elevated ICP in HIV-infected patients with cryptococcal meningitis.

Entities:  

Mesh:

Year:  2008        PMID: 18482948     DOI: 10.1258/ijsa.2007.007286

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  11 in total

Review 1.  Management of cryptococcal meningitis in sub-saharan Africa.

Authors:  Arthur Jackson; Mina C Hosseinipour
Journal:  Curr HIV/AIDS Rep       Date:  2010-08       Impact factor: 5.071

Review 2.  Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy.

Authors:  Peter R Williamson; Joseph N Jarvis; Anil A Panackal; Matthew C Fisher; Síle F Molloy; Angela Loyse; Thomas S Harrison
Journal:  Nat Rev Neurol       Date:  2016-11-25       Impact factor: 42.937

Review 3.  New insights in the prevention, diagnosis, and treatment of cryptococcal meningitis.

Authors:  Arthur Jackson; Charles van der Horst
Journal:  Curr HIV/AIDS Rep       Date:  2012-09       Impact factor: 5.071

4.  Cryptococcal meningitis treatment strategies in resource-limited settings: a cost-effectiveness analysis.

Authors:  Radha Rajasingham; Melissa A Rolfes; Kate E Birkenkamp; David B Meya; David R Boulware
Journal:  PLoS Med       Date:  2012-09-25       Impact factor: 11.069

Review 5.  New Insights into HIV/AIDS-Associated Cryptococcosis.

Authors:  Spinello Antinori
Journal:  ISRN AIDS       Date:  2013-02-25

6.  Accuracy of noninvasive intraocular pressure or optic nerve sheath diameter measurements for predicting elevated intracranial pressure in cryptococcal meningitis.

Authors:  Henry W Nabeta; Nathan C Bahr; Joshua Rhein; Nicholas Fossland; Agnes N Kiragga; David B Meya; Stephen J Dunlop; David R Boulware
Journal:  Open Forum Infect Dis       Date:  2014-10-11       Impact factor: 3.835

Review 7.  Integrated therapy for HIV and cryptococcosis.

Authors:  Sirawat Srichatrapimuk; Somnuek Sungkanuparph
Journal:  AIDS Res Ther       Date:  2016-11-29       Impact factor: 2.250

Review 8.  Strategies to reduce mortality and morbidity due to AIDS-related cryptococcal meningitis in Latin America.

Authors:  Jose E Vidal; Augusto C Penalva de Oliveira; Rafi F Dauar; David R Boulware
Journal:  Braz J Infect Dis       Date:  2013-05-10       Impact factor: 1.949

Review 9.  Cryptococcal meningitis: epidemiology and therapeutic options.

Authors:  Derek J Sloan; Victoria Parris
Journal:  Clin Epidemiol       Date:  2014-05-13       Impact factor: 4.790

Review 10.  Treatment of cryptococcal meningitis in resource limited settings.

Authors:  Derek J Sloan; Martin J Dedicoat; David G Lalloo
Journal:  Curr Opin Infect Dis       Date:  2009-10       Impact factor: 4.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.